FRESENIUS MEDICAL CARE AG |
Market Closed -
Other stock markets
|
After market 02:36:36 pm | |||
| 39.9 EUR | +2.36% |
|
39.95 | +0.13% |
| 12:14pm | FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Warburg Research reiterates its Sell rating | ZD |
| 11:38am | FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Deutsche Bank gives a Neutral rating | ZD |
| Sales 2024 * | 19.67B 20.97B | Sales 2025 * | 20.39B 21.74B | Capitalization | 11.44B 12.19B |
|---|---|---|---|---|---|
| Net income 2024 * | 718M 765M | Net income 2025 * | 973M 1.04B | EV / Sales 2024 * | 1.09 x |
| Net Debt 2024 * | 10.05B 10.71B | Net Debt 2025 * | 9.43B 10.06B | EV / Sales 2025 * | 1.02 x |
| P/E ratio 2024 * |
16
x | P/E ratio 2025 * |
11.8
x | Employees | 119,845 |
| Yield 2024 * |
2.8% | Yield 2025 * |
3.35% | Free-Float | 67.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Fresenius Medical Care AG
More recommendations
More press releases
| 1 day | +1.85% | ||
| 1 week | +13.95% | ||
| Current month | +11.84% | ||
| 1 month | +14.01% | ||
| 3 months | +10.14% | ||
| 6 months | +22.04% | ||
| Current year | +5.03% |
1 week
34.89
40.38
1 month
34.1240.38
Current year
33.8841.62
1 year
30.1649.62
3 years
25.9571.14
5 years
25.9581.10
10 years
25.9593.82
| Managers | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 56 | 19-10-31 |
Martin Fischer
DFI | Director of Finance/CFO | 47 | 23-09-30 |
Franklin Maddux
CTO | Chief Tech/Sci/R&D Officer | 65 | 08-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 16-05-11 |
Shervin Korangy
BRD | Director/Board Member | 50 | 23-07-13 |
Marcus Kuhnert
BRD | Director/Board Member | 56 | 23-07-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.48% | 202 M€ | -.--% | ||
| 1.12% | 2 M€ | +13.56% | - | |
| 0.80% | 79 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 39.9 | +2.36% | 801 792 |
| 24-04-22 | 38.98 | +6.44% | 750,876 |
| 24-04-19 | 36.62 | +0.52% | 803,997 |
| 24-04-18 | 36.43 | +2.50% | 663,964 |
| 24-04-17 | 35.54 | +1.57% | 318,946 |
Delayed Quote Xetra, April 23, 2024 at 06:09 am EDT
More quotes
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
2024-05-06
- Q1 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.98
EUR
Average target price
39.01
EUR
Spread / Average Target
+0.06%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.03% | 12.17B | |
| -11.82% | 87.77B | |
| +14.64% | 82.08B | |
| +13.31% | 30.03B | |
| -10.66% | 17.08B | |
| -5.65% | 14.45B | |
| +4.44% | 12.37B | |
| -31.40% | 11.89B | |
| +26.50% | 11.62B | |
| 0.00% | 10.72B |
- Stock Market
- Equities
- FME Stock
